Clinical Trial Update: A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption [Phase 1]

View source ↗

Summary

This Phase 1 trial from Pfizer assessed the absorption of PF-03882845 in healthy volunteers when given as a tablet versus a suspension and the effect of food on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF 03882845

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED